Conducting Assessments Without Proper Blinding Nets Investigator Warning Letter

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Conducting Assessments Without Proper Blinding Nets Investigator Warning Letter

J.W. Schomisch

January 2, 2024 at 12:32 PM EST

A clinical investigator received a Warning Letter for conducting protocol-required assessments without proper safety blinding. According to the Dec. 12 Warning Letter, Dr. Anish Shah, a clinical investigator at Siyan Clinical Research in Santa Rosa, Calif., failed to ensure that the investigation was conducted according to the investigational plan (21 C.F.R. §312.60). The in... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Conducting Assessments Without Proper Blinding Nets Investigator Warning Letter

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT